Podcasts about vaccine trial

CNN's Clarissa Ward got rare access to a hospital in southern Gaza where the human toll of the Israel-Hamas war was on display. Lawmakers are set to leave Washington without striking a deal to pass additional funding for Israel and Ukraine. The drugmakers behind an experimental cancer treatment report more progress for people with high-risk forms of melanoma. A woman is suing a Boston fertility doctor for allegedly inseminating her mother with his own sperm secretly. Plus, NASA lost contact with one of the longest-operating spacecrafts in history. Learn more about your ad choices. Visit megaphone.fm/adchoices

An investigation was published recently in the British Medical Journal that outlined how Pfizer failed to disclose to pregnant women the risks that were potentially present in their vaccine trials.

News

News

News

Pfizer needed Emergency Use Authorization to protect itself from lawsuits surrounding its dangerous Covid shots, and a new report suggests the coverup of myocarditis was coordinated by Joe Biden's White House. Why did Bill Gates buy more than a million shares of BioNTech in September of 2019? Three months before the pandemic? TO GET EVEN RICHER... which he did. Plus, New Zealand reveals staggering data about deaths and adverse events from the jab, calling the country a crime scene that demands a full criminal investigation. WOW. Podcast Production: Bob Slone Audio Productions 

The Brakes for Breasts campaign, every October, supports breast cancer vaccine research at the Cleveland Clinic. The co-founders of the campaign, Leigh Anne Best and Laura Frank, discuss the importance of finding a cause that aligns with their values and the challenges of funding vaccine research. They discuss the initiative and how it raises funds for breast cancer research by offering free brake pads to customers in October. Dr. Justin Johnson from the Cleveland Clinic talks about the importance of a vaccine trial for triple negative breast cancer. Jennifer Davis, the first recipient of the vaccine trial, shares her experience. Our panel emphasizes the importance of community support and the potential of the vaccine trial to revolutionize cancer treatment. We are challenging the industry to reach a goal of $369,000 or even $400,000 for this year and to involve at least 500 shops. This is a simple and effective program to offer to your customer and to anyone involved to tour the lab and see the impact of their contributions. Watch Full Video Episode The start of the Brakes for Breasts initiative (00:01:11) Introduction to the Brakes for Breasts initiative and the goal of raising $400,000 and getting 500 shops signed up. Explanation of the Brakes for Breasts program (00:06:24) Explanation of how the program works, including giving customers free brake pads and donating 10% of the brake job cost to the Cleveland Clinic breast cancer research program. The lab tour and check presentation (00:08:48) Discussion about the visit to the Cleveland Clinic lab and the check presentation for breast cancer research. Jennifer's experience with the breast cancer vaccine trial (00:10:55) Jennifer shares her experience as the first recipient of the breast cancer vaccine trial, including the side effects and her motivation to participate. The importance of getting involved (00:16:55) Discussion about the enthusiasm and commitment of automotive repair shops to participate in the Brakes for Breasts campaign. Ways to support the campaign (00:17:22) Information about the resources available on the campaign's website to help shop owners engage their vendors and promote the campaign. The importance of early treatment (00:25:22) Discussion about the delay in treatment and the potential impact it had on the recipient's ability to participate in the vaccine trial. The impact of the vaccine on the recipient's perspective (00:26:00) Jennifer Davis shares how receiving the vaccine has shifted her perspective on life and given her hope for the future. Thanks to our Partner, Technician Find If you are tired of struggling to find skilled automotive technicians for your independent auto repair shop, say goodbye to the endless search and let Technician Find be your solution. We are a 'Single Stop To Staff Your Shop.' http://www.technicianfind.com Connect with the Podcast: -Join our Insider List: https://remarkableresults.biz/insider -All books mentioned on our podcasts: https://remarkableresults.biz/books -Our Classroom page for personal or team learning: https://remarkableresults.biz/classroom -Buy Me a Coffee: https://www.buymeacoffee.com/carm -The Aftermarket Radio Network:

Dave Rubin of “The Rubin Report” talks to Bret Weinstein and Jay Bhattacharya about Robert F. Kennedy Jr.'s controversial appearance on "The Joe Rogan Experience," during which he discussed how Big Pharma manipulated data during the COVID vaccine trials; Joe Rogan's attempt to set up a debate about vaccines between Robert F. Kennedy Jr. and Dr. Peter Hotez; Kamala Harris and Dr. Fauci's COVID-vaccine propaganda; Bret and Jay's participation in Ron DeSantis' COVID-19 mRNA vaccine accountability roundtable; why Bret thinks the vaccines might have possibly accelerated the growth of COVID variants; what Jay thinks the biggest mistake was in the handling of the pandemic; and much more.

Prince Harry becomes the first royal family member to testify in court in more than 100 years. Also, Dr. Natalie Azar breaks down everything you need to know about the new Melanoma vaccine. Plus, The Upside: a grand tribute to “Abuelas.” And, Melissa Joan Hart and Soleil Moon Frye in studio 1A to talk about their new short documentary-style film called “I Never Thought To Ask: A Mom's Quest For Answers.”

Researchers hope a new Australian-first trial of a universal flu vaccine might remove the need for people to get a yearly flu jab. - Para peneliti berharap uji coba baru vaksin flu universal pertama di Australia dapat menghilangkan kebutuhan orang untuk mendapatkan suntikan flu tahunan.

A personalised vaccine has been found to nearly halve the rate of recurrence and death from melanoma.See omnystudio.com/listener for privacy information.

Sorrento Therapeutics has received clearance from the US FDA to initiate clinical trials with its new mRNA vaccine against Omicron variants of the Coronavirus. One Peak, an investor in growth-stage B2B software companies in Europe and Israel, has closed its latest fund at $1 billion, Private Equity Wire reported yesterday. Israeli AI inference chip venture NeuReality has raised $35 million in series A funding. Apple added 700 new price points to the App Store. And Amazon may be close to launching Prime Gaming in India. Notes: Apple yesterday announced an upgrade to pricing tiers, adding 700 more price points, and new pricing tools that developers can use to set prices per App Store country or region and manage foreign exchange rate changes. Apple didn't say anything about the commission it charges, which currently can be up to 30 percent on in-app sales. These new features will be available for apps offering auto-renewable subscriptions starting Dec. 6. Amazon may be close to launching Prime Gaming, its subscription service that offers free access to game titles bundled with Amazon Prime and Video plans, in India, TechCrunch reports. A support page on the Prime Gaming website also mentions India as an operational market for the service, TechCrunch notes. However, users who're currently attempting to access Prime Gaming will find a message that says they are in a country where the gaming service is not available. Sorrento Therapeutics has received clearance from the US FDA to initiate clinical trials with STI-1557, its next-generation mRNA vaccine against SARS-CoV-2 Omicron variants, the Silicon Valley biopharma company said in a press release yesterday. This mRNA vaccine incorporates a modification that prevents certain unwanted side effects in vital organ tissues following the administration of the current FDA-approved mRNA vaccines. The mRNA is encapsulated in a Sorrento proprietary lipid nanoparticle formulation to protect mRNAs from degradation, which helps the vaccine retain its effectiveness, the company said in the release. In biotech venture capital news, Avalon BioVentures, a venture capital firm dedicated to early-stage biomedical innovation, yesterday announced the closing of its first venture fund, ABV1, with $135 million in funding from new and existing institutional investors. One Peak, an investor in growth stage B2B software companies in Europe and Israel, has closed the One Peak Growth III fund at its hard cap of $1 billion, Private Equity Wire reported yesterday. One Peak, which was founded by David Klein and Humbert de Liedekerke Beaufort, is the largest fund in Europe dedicated to backing fast-growing B2B software companies in the $15 million to $100 million investment range, according to the report. NeuReality, an AI hardware startup, which specializes in the next generation of AI inferencing platforms, has raised $35 million in Series A funding, the Israeli company said in a post on its website. The round was led by Samsung Ventures, Cardumen Capital, Varana Capital, OurCrowd and XT Hitech. The round brings NeuReality's total funding to $48 million. The money will support NeuReality's plans to start deploying its Inference solutions in 2023, the company said. Theme music courtesy Free Music & Sounds: https://soundcloud.com/freemusicandsounds

University Hospital's Chief Strategic Integration and Health Equity Officer, Dr Chris Pernell, participated in the Moderna COVID vaccine trial. Dr Pernell tells us what we can do to improve health equity in care and research. Speakers Sharon Hanlon, Group Director, Clinical Trial Engagement & Enrollment, Bristol-Myers SquibbChris Pernell, MD, MPH, FACPM, Chief Strategic Integration and Health Equity Officer, University Hospital

We sat down with our friends Lindsey and David to talk about medical misinformation and its effects on relationships, the challenge of choosing what to trust in the swirl of constantly changing pandemic info, and the role that communication can play in increasing access to vaccines and clinical trials. Lindsey and David also tell the story of their family's participation in clinical trials for the COVID vaccines, and the surprising ways it changed their views on social media and the medical research process.

A look inside a COVID vaccine trial at Hattiesburg Clinic. Then, is the Gulf Coast's climate ready for a new fruit? See acast.com/privacy for privacy and opt-out information.

BioVaxys Technology Corp CEO James Passin tells Proactive it has confirmed its first clinical site for its Phase I ovarian cancer vaccine trial. The study on BVX-0918, the company's autologous haptenized tumor cell vaccine for late-stage ovarian cancer, will take place at Hospices Civils de Lyon in France, according to a company statement. HCL has also agreed to supply BioVaxys with surgically debulked tumors from Stage III/Stage IV ovarian cancer patients undergoing treatment at the hospital to allow the company to perform manufacturing tests.

On today's show, we talked about a guy who voluntarily got dysentery. For the whole podcast, as well as a ton of other exclusive perks, sign up to be a Fancy Idiot at FreeBeerAndHotWings.com! See acast.com/privacy for privacy and opt-out information.

Moderna has announced that the first HIV vaccine dose has been administered in a trial patient. This is 41 years after the first documented case. This weekend we lost two pubic figures to suicide, Mayor Kevin Ward & Cheslie Kryst. Let's remember them today.  00:00 - Welcome & Intro 00:30 - The Qube Ad 00:54 - Intro Music 01:34 - Moderna has announced that the first HIV vaccine dose has been administered in a trial patient. This is 41 years after the first documented case 03:55 - This weekend we lost two pubic figures to suicide, Mayor Kevin Ward & Cheslie Kryst. Let's remember them today. 06:58 - Anna's Got A Word  About Queer News An intersectional approach to daily news podcast where race & sexuality meet politics, entertainment and culture. Tune-in to reporting which centers & celebrates all of our lesbian, gay, bisexual, transgender, queer & comrade communities. Hosted by Anna DeShawn. 7 minutes a day, 5 days a week, ready by 9 a.m. We want to hear from you. Tune in and tell us what you think. email us at info@e3radio.fm. follow anna deshawn on ig & twitter: @annadeshawn. and if you're interested in advertising with “queer news,” write to us at info@e3radio.fm.

Since early November, many children ages 5 to 11 have received the Pfizer COVID-19 vaccine. But before this could happen, Pfizer had to test the vaccine in a trial. Children's of Alabama pediatric hospitalist Dr. Erinn Schmit entered her son in that trial. She explains why she wanted to have him participate and what it means to her family to play a role in this process.

Today on the Naturally Inspired Daily Clip Tammy Talks About: The new whistle blower and the data integrity issues from the Pfizer vaccine trial.  

The British Medical Journal (BMJ) has alleged serious issues with Pfizer's vaccine safety trials, including claims of “falsified data” after a whistleblower reported concerns. This is my opinion. Check out the links below for more information and thanks for listening to The Slippery Slope. British Medical Journal: "Researcher Blows the Whistle on Data Integrity Issues in Pfizer's Vaccine Trial" | naked capitalism Covid-19: Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial | The BMJ Pfizer vaccine trial BMJ report: Whistleblower raises data, safety concerns at contractor Ventavia | news.com.au — Australia's leading news site --- Send in a voice message: https://anchor.fm/jason-fallon/message

Catch up on what you missed on an episode of The Richard Syrett. An Investigative Journalist, Paul D. Thacker talks about his article in the BMJ titled: “Researcher blows the whistle on data integrity issues in Pfizer's vaccine trial.” Richard along with caWsbar (Canadian Women's Sex-Based Rights) fight back against radical gender ideology. Plus, Editor of World Net Daily's Whistleblower Magazine, David Kupelian shares more on the latest issue titled: “THE GREAT AMERICAN REBELLION: ‘We will not comply!' COVID-19 power grab ignites bold new era of national defiance.

As many of you know, for the past ten years I have been a passionate advocate for what we dubbed, “The Pink Vaccine.“  This vaccine was developed at the Cleveland Clinic in Ohio under the direction of Dr. Vincent Tuohy at the Learner Research Institute. For the past four years, I have been honored to serve as a patient advocate for the Phase I clinical trial for Dr. Tuohy's vaccine. It is with great pleasure and overwhelming excitement, that I can now announce and encourage patients to apply to participate in the Phase I clinical trial. Finally, this vaccine is transitioning from bench to bedside, and will be directed by Dr. Thomas Budd at the Taussig Cancer Center at the Cleveland Clinic.  To participate in this trial, patients must meet the following criteria:  Ø      Diagnosed with Triple Negative Breast Cancer Ø Be Within three years of completing treatment Ø       NED – confirmed by their oncologist in writing to be No Evidence of Disease Full details of the trial may be found on clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT04674306?term=Cleveland+Clinic&cond=Triple+Negative+Breast+Cancer&cntry=US&state=US%3AOH&draw=2&rank=1 Those meeting the above criteria for participation may email: CancerAnswer@CCF.org For more information, you may also visit my website: http://www.Sisters4Prevention.com or email me at Sisters4Prevention@yahoo.com.   I would like to thank everyone who donated or supported me in my advocacy efforts for this vaccine. You have always responded generously with your time and talent. Please know that this milestone in finding a cure for breast cancer by prevention would not have been possible without your love, efforts and support over the last ten years.  Now friends the best is yet to come.  We can finally test this vaccine and hope to Imagine a World Without Breast Cancer and realize that Prevention is the Cure. #PinkVaccine    #PreventionIsTheCure   #BreastCancerVaccine  #PreventBreastCancer #PrimaryPrevention #StopBreastCancer #WorldWithoutBreastCancer  Support the show

With its low rate of COVID-19 vaccinations, Australia is in the rare position of being able to continue vaccine trials on unvaccinated people. This is especially necessary because even vaccines with high efficacy, such as Pfizer and AstraZeneca, have no guarantee of remaining effective as the virus mutates.  Today Cosmos journalist Ellen Phiddian talks to Adelaide's Dr Chris Rook, fellow of the Royal College of General Practitioners, who will be conducting a phase III clinical trial of a protein vaccine. But even though vaccine trials are necessary, it's still a long process from conception to approval. So how do you run a vaccine trial in Australia?Find the science of everything at the Cosmos Magazine website Subscribe to Cosmos Magazine (print) or the Cosmos WeeklyWatch and listen to all our Cosmos Briefings

Greg Sarchet, PharmD, is a Commander and Commissioned Corps Officer in the United States Public Health Service. He is the Director of Professional Services with responsibility for 8 departments at the Whiteriver Indian Hospital in Whiteriver, AZ. Greg is a childhood friend of mine as we went to school together from first grade all the way through pharmacy school. It was great to catch up with him as we talk through his career path in the Indian Health Service including working as an Emergency Medicine Clinical Pharmacist, serving as the Lead Pharmacist for the NIH's Ebola vaccine trial in Liberia, and his passion on improving vaccination rates in the White River community. It was great to catch up with him and learn about life in the USPHS! 

Everyone's favourite blue glasses-wearing doctor, Paul Griffin, gives us the lowdown on the new trial being run at the Mater Hospital on a new protein-based COVID-19 vaccine... Follow Ash, Kip & Luttsy with Susie O'Neill! Facebook: www.facebook.com/ashkipluttsyandsusieoneill  Twitter: www.twitter.com/AKLS_nova  Instagram: www.instagram.com/ashkipluttsyandsusie  See omnystudio.com/listener for privacy information.

Chi Yeh is an interior designer, mother of two and immigrant from Laos. In this episode, Chi talks about coming to America at the age of 4 with three other siblings and a family that had nothing to their name. Chi reflects on the work ethic her parents instilled in her and how she was able to raise a young son as a single mother because of this.She also talks about the inspiration for her business as an interior designer as well as the challenges she still faces as a woman working with contractors on a job site.Chi's journey from immigrant, to single mother, to nursing student to re-married with a new interior design business is the ultimate proof of just how possible it is to achieve your dreams in America if you are willing to put in the work and sacrifice that is required of it.You can reach chi on her website (designsbychi.com):designsbychior on her Instagram @designsbychi

Moderna's mRNA technology could help in the decades-long search for an HIV vaccine. The company said it expects to begin two vaccine trials in humans by the end of 2021. HIV researchers caution there's a long road ahead for mRNA vaccines. Former Minneapolis Police Officer Derek Chauvin was convicted Tuesday of murdering George Floyd. It took the jurors less than 12 hours to reach their decision of guilty on 3 counts. Chauvin could face up to 40 years in prison. HEADLINES Meteorologist fired over Facebook post has now sued the tv station for anti-LGBTQ harassment & mistreatment Marjorie Taylor Greene wants a drag queen “arrested & charged” for being near children An Oklahoma trans woman was denied a COVID vaccine because she had a “mismatched ID” At least four teens at one clinic in Arkansas have reportedly attempted suicide in the two weeks since the state banned gender-affirming health care for transgender minors. The GOP House members planned to start an “Anglo-Saxon” caucus. --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/the-coma-cast/message Support this podcast: https://anchor.fm/the-coma-cast/support

In this episode, we speak with Stanley Wang, a participant in phase 2/3 of the Pfizer COVID-19 Vaccine Trial. We discuss the timeline for vaccine trials, as well as why he felt compelled to participate.

After months of devastating loss, Louis said "fuck it" (literally) and enrolled himself in the Pfizer vaccine trial. Louis, a self-described "big ol' meat shield," was more than happy to take this risk, especially because he knows we aren't going to get anywhere with this virus until we start finding some answers. He goes into detail about why he chose to participate, how it went, and what happened after injection. If you want to find out whether or not he received the vaccine or a placebo, tune in! 

Having worked in biotechnology and pharmaceutical manufacturing for the last decade, Andrew is no stranger to the type of studies that have been employed to test the recent surge of COVID-19 vaccines.After deciding to volunteer in one of these studies, Andrew filled out a survey expressing his interest and was contacted a few months later by a representative from AstraZeneca. On the day of his appointment at the pharmaceutical company, Andrew received a regular medical exam before being given the first shot of the study.The injection was either the active vaccine or a placebo and this knowledge will be withheld from Andrew until the completion of the study two years from now, or if he decides at any time to opt-out. The placebo is included in the study to discourage participants from altering their day to day behavior as they might if they knew for sure it was the actual vaccine they were receiving.Andrew states that he has not experienced any side effects other than the regular muscle ache usually present after a flu shot. Furthermore, the AstraZeneca vaccine was approved in the U.K. just this week and the first doses are set to be administered on Monday.RELATED EPISODEEPISODE 57 - Should I get the Covid Vaccine? 

Medical News Today's Research Editor, Dr Yella Hewings-Martin investigates what participating in Covid-19 vaccine clinical trial is like. Pharmacist and Drug Content Integrity Manager at Healthline Media, Lindsay Slowiczek, joins Nathan Richardson, Vice Executive President at Red Ventures for this discussion. A podcast for Medical News Today. Read more at medicalnewstoday.com

OHSU has gathered 13,000 volunteers for its Phase 3 AstraZeneca coronavirus vaccine trial. The university is the only Oregon institution participating in the nationwide trial. We speak with Dr. Marcel Curlin, the lead researcher of the study and associate professor of medicine within OHSU's infectious disease division.

My long-time friend, Kristen, is an assistant professor of nursing and public health at UCLA. She a PhD in nursing, a masters in public health, and am a practicing registered nurse. We get into her experience taking the COVID-19 vaccine during the trials but more importantly we get to hear her thoughts about healthcare reform and how working as a researching scientist has helped shape her worldview. To support this podcast on patreon: www.patreon.com/storyfeast If you liked the music, check out Graham Low's band: www.pajamasband.com To contact me: heygeej@gmail.com

Stocks fell Wednesday afternoon, reversing earlier gains after new data from Pfizer (PFE) helped momentarily stoke investor confidence that an effective vaccine will become available in the coming months. The pharmaceutical company reported Wednesday that it had concluded its Phase 3 trial of its vaccine candidate, and found its inoculation to be 95% effective against COVID-19.

Preliminary data from Moderna's coronavirus vaccine trial is an "spectacular accomplishment," according to Dr. Timothy Shacker from the University of Minnesota Medical School.Are schools more dangerous to young students than restaurants? Dr. Nathaniel Beers from Children's National Hospital in Washington D.C. explains. Hospitals in the Midwest are postponing non-urgent procedures to make room for COVID-19 patients. Dr. Chris Colbert from the Emergency Medicine Residency Program at University of Illinois/Chicago describes what he and his fellow doctors are experiencing. Many American families are planning to have Thanksgiving dinner despite a spike in coronavirus cases. Can you and your family be protected from the virus if everyone gets tested before the holiday? Dr. Patrick Godbey from the College of American Pathologists explains.  To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

See omnystudio.com/listener for privacy information.

Julia Chatterley is live from New York. Here are the top business news stories today! Democrats dilemma - Nancy Pelosi blames republicans for stimulus stalemate. 5-geepers! Apple announces 4 new iPhones that are 5g ready. Pressing pause – Johnson & Johnson halts vaccine trial over safety concerns. It’s Wednesday, let’s make a move.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

While surveys have found many Americans — particularly Black Americans — are wary of getting a COVID-19 vaccine if one were to become available soon, New Jersey public health doctor Chris Pernell has jumped in feet first, signing up as a subject for a Phase III clinical vaccine trial at Rutgers University. She says it’s important for Black people like her to be included in clinical trials to ensure the results reflect the general population, and because Black Americans have been hit the hardest by the virus. But her decision to enroll was also personal: a tribute to her scientist father who died of COVID-19.

Some participants in the Moderna and Pfizer vaccine trials are reporting side effects such as fevers, body aches, chills and exhaustion as Reuters reports the FDA is expanding a safety probe into a AstraZeneca vaccine.Workers are starting to head back to their offices. But are businesses ready to provide a safe environment for employees?While much of the nation focuses on the coronavirus pandemic, the number of opioid-related deaths is surging.Hollywood heavyweights and movie theater owners are pleading with Congress for a bailout.A Finnish study shows many people are having nightmares about COVID-19. To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy Learn more about your ad choices. Visit https://podcastchoices.com/adchoices

Julia Chatterley is live from New York. Here are the top business news stories today! Green revolution! China pledges to be carbon neutral by 2060. Johnson & Johnson begins final stage of its one-dose Covid19 vaccine trial. The $25k Tesla? Elon Musk unveils new battery technology that will drive down costs. It’s Wednesday, let’s make a move. Halfway through the show, Justice Ruth Bader Ginsburg’s casket arrives at the Supreme Court to lie in repose – we end early to bring in live footage of the historic ceremony.To learn more about how CNN protects listener privacy, visit cnn.com/privacy

“These trials can fail. There's going to be some unexpected twists and turns here and you need to be ready for that as an investor.” Brad Loncar assesses how to play the biotech space after news breaks of AstraZeneca pausing vaccine trials.

Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt

What is it like participating in one of the COVID-19 vaccine trials running right now? Many people want to know as the world rushes to educate themselves in what the expedited vaccine development process looks like. Richard Fisher wrote a piece for BBC about his participation in Oxford University's trial. The trial has ten thousand participants and is putting Oxford's vaccine against a common meningitis vaccine as the control. Why not use a placebo? Well, researchers wanted to ensure both groups receive common vaccination side effects. Richard will fill out a weekly questionnaire, take tonsil and nasal swabs, and report for periodic blood tests for the next year. He writes: “It's this necessary but long-term process that some people – many of them politicians – fail to understand about the coronavirus vaccine trials. You can't throw money at the problem and hope results happen faster. While the Oxford vaccine trial has already shown promising safety results, and the tantalising possibility of a protective immune response, it was only in 1,000 people. To roll out a vaccine to millions (or the whole world), you need a level of confidence that can only come with patience and more data.Public health officials will remember well the times that vaccine rollouts went wrong. In 1976, fears of a swine flu outbreak led the US government to accelerate vaccine development and inoculate tens of millions of Americans. The feared pandemic never arrived, but by some estimates, around 30 people died due to adverse vaccine reactions. Such mistakes may well have dented trust in public health advice and fuelled anti-vax fears too, which is the last thing you need in a pandemic.”Please be sure to like, subscribe, provide a five-star rating, and write a review. It's free to you and means the world to me. Thank you for listening, and I'll catch you tomorrow. 

On the Vox Markets Podcast Today: 28th July 2020 Cathal Friel, Executive Chairman of Open Orphan #ORPH discusses the contract they've been awarded from Codagenix for a COVID-19 Vaccine Trial. Glen Goodman, former ITV News Business correspondent and now author of, "The Crypto Trader", covers this week's Bitcoin breakout. (Interview starts at 21 minutes 10 seconds) Plus the Top 5 Most Followed Companies & the Top 5 Most read RNS's on Vox Markets in the last 24 hours. Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community. #VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast https://www.voxmarkets.co.uk/

Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt

Dr Ellie Cannon is taking part in the human trials after she signed up for the Oxford vaccine trial. She spoke to Niall Boylan on Monday afternoon explaining how exactly the trial works.See omnystudio.com/listener for privacy information.

Catch up on the most important news today in 2 minutes or less. Get even more news you can use with the Tech in Two newsletter. Sign up here: https://www.wired.com/tt